Synergy’s newly formed subsidiary, ContraVir Pharmaceuticals, Inc., the company which will hold the FV-100 assets (“ContraVir”), has filed a Form 10 Registration Statement (“Form 10”) with the U.S.

Synergy CHC (NASDAQ:SNYR) filed to sell 1.28 million shares of common stock. This prospectus is not an offer to sell these securities. Filing Synergy CHC secures retail deals with McKesson Canada and ...

16:43 EST Synergy CHC (SNYR) files $100M mixed securities shelf Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks ...